Back to pollutant grid

Pollutant removal

Endocrine Disruptors (EDCs)

Overview & Sources

Endocrine Disrupting Chemicals (EDCs) are exogenous substances or mixtures that alter function(s) of the endocrine system and consequently cause adverse health effects in an intact organism, its progeny, or (sub)populations. EDCs interfere with the synthesis, secretion, transport, binding, action, or elimination of natural hormones in the body that are responsible for the maintenance of homeostasis, reproduction, development, and/or behavior.

Key characteristics making EDCs particularly challenging for water treatment include:

  • Low-Dose Activity: Some potent endocrine-active compounds can produce effects at concentrations in the ng/L to µg/L range. Potency, species, exposure duration and endpoint differ; not every chemical in this broad category has the same low-dose effect. Trace analysis and target-specific treatment are therefore important.
  • Diverse Chemical Structures: Confirmed or suspected endocrine-active chemicals occur among pharmaceuticals (e.g., 17α-ethinylestradiol), pesticides (e.g., atrazine, DDT), industrial chemicals (e.g., Bisphenol A (BPA), selected phthalates and PCBs), dioxins and personal care products. Membership in a broad product class alone does not establish endocrine-disrupting activity for every constituent.
  • Persistence and Mobility: Some EDCs are highly persistent in the environment, resisting degradation and partitioning into various environmental compartments, including water.

Primary sources of EDCs in aquatic environments include:

  • Municipal Wastewater Discharges: Incomplete removal in conventional wastewater treatment plants allows pharmaceuticals, personal care products, and household chemicals to enter receiving waters.
  • Industrial Effluents: Discharges from chemical manufacturing, plastics production, pulp and paper mills, and pharmaceutical industries.
  • Agricultural Runoff: Pesticides, herbicides, and veterinary pharmaceuticals used in farming can leach into surface and groundwater.
  • Landfills: Leachate from landfills containing discarded products can be a source of various EDCs.

Environmental & Health Impact

The environmental and health impacts of EDCs are significant due to their ability to disrupt fundamental physiological processes.

Environmental Impacts:

  • Aquatic Ecosystems: EDCs can cause feminization of male fish, reduced fertility, altered sexual development, and changes in behavior in aquatic organisms. This has been widely observed in fish populations exposed to estrogenic compounds, leading to skewed sex ratios and potential population decline.
  • Biodiversity Loss: Chronic exposure to EDCs can impair reproduction and development across multiple trophic levels, threatening species viability and ecosystem stability.
  • Bioaccumulation and Biomagnification: Some persistent, lipophilic endocrine-active chemicals can accumulate in tissues and biomagnify through food webs. This behavior is compound-specific and cannot be assigned to every EDC.

Human Health Impacts: Experimental and epidemiological evidence has linked particular endocrine-active chemicals to the outcomes below, with different strengths of evidence. Hazard depends on the compound and dose, while exposure route, duration and developmental timing determine risk. These findings do not establish that every trace detection in drinking water causes all the listed diseases.

  • Reproductive Disorders: EDCs are linked to decreased sperm quality, reduced fertility, altered menstrual cycles, and increased risk of endometriosis and polycystic ovarian syndrome.
  • Developmental Effects: Exposure during critical windows of fetal and childhood development can lead to neurodevelopmental disorders, altered sexual development, and impaired immune function.
  • Metabolic Disorders: Emerging evidence links EDCs to increased risk of obesity, type 2 diabetes, and metabolic syndrome.
  • Carcinogenic Potential: Some EDCs are suspected or known carcinogens, associated with increased risks of hormone-sensitive cancers (e.g., breast, prostate, testicular). The challenge in assessing impacts is often compounded by the "cocktail effect," where exposure to multiple EDCs at low concentrations can produce synergistic or additive adverse effects not predicted by individual chemical assessments.

Regulatory Standards

Regulatory approaches for EDCs are complex, often focusing on individual compounds rather than the entire class, given their diverse chemical structures and mechanisms of action. Many EDCs are regulated under existing frameworks for pesticides, industrial chemicals, or pharmaceuticals. The absence of a universal regulatory standard for "EDCs" as a group underscores the scientific and policy challenges.

OrganizationKey Regulatory Approach / FocusSpecific Limits (Drinking Water)Notes
WHOCompound-specific drinking-water risk assessment, hazard identification and exposure controlAtrazine plus its chloro-s-triazine metabolites: 0.1 mg/L (100 µg/L). Hydroxyatrazine: 0.2 mg/L (200 µg/L).WHO guidance values are not a universal EDC limit. The frequently quoted 2 µg/L describes occurrence, not the current atrazine guideline.
US EPAEndocrine Disruptor Screening Program (EDSP) for testing chemicals. Regulation of specific compounds under Safe Drinking Water Act (SDWA), Clean Water Act (CWA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Toxic Substances Control Act (TSCA).Atrazine: MCL 3 µg/L. 2,4-D: MCL 70 µg/L. Phthalates (e.g., Di(2-ethylhexyl)phthalate): MCL 6 µg/L.Focus on monitoring programs and research. Many EDCs are on the Contaminant Candidate List (CCL) for future regulation consideration.
China GBGB 5749-2022 regulates specified drinking-water chemicals; wastewater requirements depend on the applicable discharge frameworkTable 3: volatile phenols (as phenol) 0.002 mg/L; di(2-ethylhexyl) phthalate 0.008 mg/L; atrazine 0.002 mg/L.These limits apply to the named parameters, not all phenols or all phthalates. Appendix A lists BPA at 0.01 mg/L as a reference indicator, distinct from the mandatory table limits.
EFSADietary risk assessment of BPA, not a drinking-water concentration standard2023 TDI: 0.2 ng/kg body weight/day; replaces the 2015 temporary TDI of 4 µg/kg body weight/day.The previous value was an EFSA assessment, not a WHO drinking-water limit. A daily intake must not be directly compared with a water concentration without an exposure calculation.

Note: The absence of a single "EDC" limit reflects the complexity of the group. Regulation typically addresses individual chemicals known to exhibit endocrine-disrupting properties under broader chemical control or pollutant discharge frameworks.

Removal Technologies

The effective removal of EDCs from water is challenging due to their low concentrations, diverse chemical structures, and often high recalcitrance to conventional treatment. A multi-barrier approach, often involving advanced technologies, is typically required.

Membrane Solutions

Membrane processes can separate many EDCs from water, but performance depends on the individual compound and membrane. Rejection must be tested under relevant water chemistry and operating conditions, and separation transfers the rejected mass to concentrate.

  • Nanofiltration (NF): NF can reject many larger or charged EDCs. Performance depends on molecular weight cut-off (MWCO), solute size, charge and hydrophobicity, membrane material, pH and operating conditions; small neutral compounds may be less well retained. Nominal pore descriptions alone do not establish removal of every target.
    • Engineering Considerations: Pretreatment is critical to prevent organic and inorganic fouling, which can reduce flux and increase cleaning frequency. Concentrate management is a significant operational challenge and cost factor, as EDCs are concentrated in the reject stream.
  • Reverse Osmosis (RO): Dense RO selective layers often provide high rejection of many EDCs. Small neutral organics can pass to varying degrees, so RO is not a guarantee of complete removal of nearly all organic contaminants. Verify the target compounds, membrane integrity and operating conditions.
    • Engineering Considerations: High energy consumption, significant pretreatment requirements to avoid scaling and fouling (particulate, organic, biological), and the production of a highly concentrated brine stream are key operational considerations. RO systems demand stringent chemical dosing and membrane cleaning regimes.

Adsorption Solutions

Adsorption processes are well-established for removing organic contaminants, including many EDCs, by accumulating them on a solid surface.

  • Granular Activated Carbon (GAC): GAC is widely used due to its high surface area and porous structure, which can effectively adsorb a wide range of organic EDCs, particularly hydrophobic compounds.
    • Engineering Considerations: Adsorption capacity is finite; breakthrough occurs when the GAC bed becomes saturated. Regeneration (thermal or chemical) is energy-intensive and can be costly, or spent GAC requires proper disposal. Competitive adsorption with natural organic matter (NOM) can reduce EDC removal efficiency and bed life.
  • Powdered Activated Carbon (PAC): PAC can be dosed intermittently or continuously into treatment processes (e.g., coagulation/flocculation, sedimentation tanks) to provide rapid adsorption.
    • Engineering Considerations: PAC requires efficient separation from the treated water, often via sedimentation and filtration. It is typically a single-use adsorbent, leading to significant sludge management challenges.
  • Polymeric Adsorbent Resins: Synthetic resins, often macroporous, can be tailored for specific selectivities towards certain classes of EDCs (e.g., ion exchange resins for charged EDCs or non-ionic resins for hydrophobic EDCs).
    • Engineering Considerations: Resins can have higher capacities and regenerability than GAC for specific compounds, but capital and operating costs can be higher. Fouling by NOM can also be an issue.

Chemical/Biological

These methods aim to degrade or transform EDCs rather than simply separating them.

  • Advanced Oxidation Processes (AOPs): Processes using Ozonation (O3), UV/H2O2, O3/H2O2 and Fenton (Fe2+/H2O2) or photo-Fenton chemistry can generate hydroxyl radicals (•OH) and other oxidants that transform many EDCs. Loss of the parent compound does not prove mineralization, lower toxicity or removal of endocrine activity; transformation products and residual activity must be assessed.
    • Engineering Considerations: AOPs are highly effective for many EDCs but are energy-intensive. They can also lead to the formation of transformation products, some of which may retain endocrine activity or have other toxicities, necessitating careful monitoring. Scavenging of hydroxyl radicals by natural organic matter can reduce efficiency.
  • Biological Treatment:
    • Conventional Activated Sludge (CAS): While CAS can partially remove some more biodegradable EDCs through biodegradation and adsorption to sludge, many recalcitrant EDCs pass through largely unaffected. Removal efficiency varies widely based on sludge retention time (SRT), hydraulic retention time (HRT), and microbial community.
    • Enhanced Biological Processes (e.g., Membrane Bioreactors (MBR), Anaerobic/Aerobic Systems, Biofilm Reactors): MBRs offer longer SRTs and better biomass retention, enhancing the biodegradation of some EDCs. Specific microbial consortia or engineered bioreactors can be developed to target particular recalcitrant EDCs.
    • Engineering Considerations: Biodegradation efficiency is highly dependent on EDC molecular structure, concentration, and environmental conditions (e.g., pH, temperature, presence of co-substrates). Sludge disposal remains a concern, as some EDCs can accumulate in the biomass.

Technical Comparison Table

TechnologyRemoval Efficiency (EDCs)Capital CostO&M CostPretreatment NeedsByproduct FormationEnergy IntensityApplicability/Considerations
Membrane (NF/RO)High to Very HighHighHighVery HighConcentrate streamHighBroad, but concentrate management is key.
Adsorption (GAC)Moderate to HighModerateModerateModerateSpent media/regenerationLowEffective for hydrophobic EDCs. Finite capacity.
Chemical (AOPs)HighModerateModerateModerateTransformation productsHighEffective degradation. Requires careful monitoring.
Biological (Enhanced)Low to Moderate (variable)ModerateModerateLow to ModerateSludge accumulationLow to ModerateDependent on EDC biodegradability and system design.

Note: Qualitative bands are provided. Actual performance depends heavily on specific EDC characteristics, water matrix, and system design/operation.

AquaChain Engineering Tip

When designing treatment schemes for EDCs, always consider a multi-barrier approach. EDCs' diverse chemistry and often low-concentration, high-impact nature necessitate robust pretreatment, often combining physical separation (e.g., coagulation/flocculation to remove particulate-bound EDCs and NOM) with advanced processes like NF/RO or AOPs. Pilot testing with actual water matrices is crucial to optimize chemical dosages, select appropriate membrane types, and predict adsorbent bed life, minimizing unexpected operational costs and ensuring compliance. Remember to account for potential transformation products and concentrate disposal.

FAQ

Q: Why are EDCs so challenging to remove compared to conventional pollutants? A: Their chemical diversity, trace concentrations, and compound-specific resistance to conventional biodegradation make analysis and treatment difficult. Some potent endocrine-active compounds can act at nanogram-per-liter levels, but this is not a universal effect threshold for all EDCs. Target selection and validated treatment are essential.

Q: What is the primary concern for membrane processes when treating EDCs? A: The primary concerns for membrane processes like NF and RO are significant pretreatment requirements to mitigate fouling (organic, inorganic, biological) and the challenge of managing the concentrated reject stream containing EDCs, which requires further treatment or careful disposal.

Q: Are Advanced Oxidation Processes (AOPs) a silver bullet for EDC removal? A: While AOPs are highly effective at degrading a broad range of EDCs, they are energy-intensive and can sometimes produce transformation products that may retain endocrine activity or possess new toxicities. Careful optimization, monitoring, and consideration of transformation products are crucial.

Recommended AquaChain Guide solution

Advanced Oxidation Processes (AOPs), Nanofiltration (NF), Granular Activated Carbon (GAC), biological treatment.

VontronCRRC